U1 snRNA mutation reshapes tumor microenvironment in chronic lymphocytic leukemia: a role for CD44-mediated signaling
Authors:
- Sara López-TamargoSLSara López-Tamargo
- Javier Fernández-MateosJFJavier Fernández-Mateos
- Pablo Bousquets-MuñozPBPablo Bousquets-Muñoz
- Laura Llaó-CidLLLaura Llaó-Cid
- Ferran NadeuFNFerran Nadeu
- Cristina Olivar-FernándezCOCristina Olivar-Fernández
- Ana de la Fuente-GonzálezAFAna de la Fuente-González
- Andrea AranAndrea Aran
- Roberto Martínez-SolerRMRoberto Martínez-Soler
- Europa Azucena GonzálezEGEuropa Azucena González
- Manel JuanManel Juan
Preprint
Abstract
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of monoclonal mature B lymphocytes in peripheral blood, bone marrow, lymphoid tissues, and extranodal sites. Genes involved in RNA splicing such as SF3B1 and U1 are frequently mutated in CLL, leading to altered splicing and generation of tumor neoepitopes. To study the impact of these mutations on the tumor microenvironment (TME), we have developed a comprehensive single-cell atlas of unmutated CLL encompassing 26 bone marrow and lymph node tumor samples from 23 U-CLL patients with mutations in U1 (n=7), SF3B1 (n=8), or without mutations in splicing genes (n=10). We observed high intra-tumor heterogeneity, discerning 12 transcriptional programs, one linked to the U1 g.A3>C mutation and characterized by NFKB hyperactivation. T cell and NK compartments exhibited site- and mutation-specific enrichment, with increased CD4 + regulatory cells (Treg) and CD8 + exhausted cells in lymph nodes, while U1 -mutant tumors showed increased CD8 + cytotoxic activity, with a predominance of effector-like CD8 + cells. Single-cell T cell receptor sequencing revealed clonotype expansion in U1 -mutated tumors, particularly in CD8 + effector and exhausted cells, suggesting a neoantigen-driven immune response. Cell-to-cell interaction analysis identified CD44 as a key mediator in U1 -mutated tumors, showing pro-B survival interactions as those involving MIF-CD44-CD74. Furthermore, interactions between CD80 on CLL cells and CTLA4 on Tregs and CD8 + exhausted were upregulated, reflecting an immunosuppressive phenotype associated with U1 mutated CLL. These findings highlight the complex interplay between mutations in CLL and the TME, offering novel avenues for alternative therapeutic strategies for U-CLL with mutations in U1 .Keywords
This publication has 56 references indexed in Scilit:
- Combining LIANA and Tensor-cell2cell to decipher cell-cell communication across multiple samplesCell Reports Methods, 2024
- Exhausted CD8+ T cells face a developmental fork in the roadTrends in Immunology, 2023
- Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroupsLeukemia, 2017
- Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumorsNature Genetics, 2016
- Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch PointCell Reports, 2015
- Mutations driving CLL and their evolution in progression and relapseNature, 2015
- Non-coding recurrent mutations in chronic lymphocytic leukaemiaNature, 2015
- Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with PrognosisCell, 2015
- Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemiaNature Genetics, 2011
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemiaNature, 2011